Skip Navigation

QJM 2009 102(2):79-80; doi:10.1093/qjmed/hcp003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bannon, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bannon, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Elements: In this month's issue

The first 10% of the full text of this article appears below.

There are three review articles in this month's issue of QJM; two of which have undertaken an historical discussion of the topic in question. The first by Thompson considers what is commonly known as the "cholesterol controversy". QJM has published about 25 research and review papers that deal with either lipids or statins over the past 3 years. On briefly reviewing them, most (if not all) of these papers describe either research or opinions that are ultimately . . . [Full Text of this Article]

Michael Bannon

Editor QJM


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?